Trials / Completed
CompletedNCT00653913
Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)
Evaluation of Potential for Pharmacokinetic Drug Interaction Between SCH 58235 and Pitavastatin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Male
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study was designed to evaluate the pharmacokinetic interaction and safety of coadministration of SCH 58235 (ezetimibe) and pitavastatin in healthy Japanese adult male subjects or adult male subjects having no obvious disease other than high cholesterol levels.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SCH 58235 | SCH 58235 10 mg (once daily) |
| DRUG | pitavastatin | Pitavastatin 2 mg (once daily) |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2004-09-01
- Completion
- 2004-09-01
- First posted
- 2008-04-07
- Last updated
- 2022-02-16
Source: ClinicalTrials.gov record NCT00653913. Inclusion in this directory is not an endorsement.